Fundraising Fox
/Companies
Sign in

DemeRx

Fort Lauderdale, US · Founded 2010 · Florida corporation

Find your way into DemeRx

Sign up to see every warm intro you have to DemeRx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the DemeRx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

DemeRx develops psychedelic-based medications to treat addiction and mental health conditions. The company advances clinical trials for ibogaine and related compounds targeting alcohol use disorder and opioid addiction.

BiotechDigital HealthMental Health

Founders & leadership

DemeRx was founded in 2010 by Deborah C. Mash.

DCDeborah C. Mash
Deborah C. MashDeborah C. Mash has expertise in small molecule development, pharmacology, addiction neurobiology, and neuroscience, and is founder of DemeRx, which develops psychedelic-based medications for addiction and mental health conditions.
HW
Holger WeisExecutive
JL
Jeffrey L. RaneyExecutive
SG
Steve GorlinNamed on SEC filing

Board

HM
Henry MellonBoard director
CK
Charles KoobBoard director
BH
Bruce HackBoard director
PN
Peter NejesBoard director
SC
Skip ClemmonsBoard director

Reported raises · per SEC filings

Form D private placements

$289.6K disclosed across 1 round · 2015

▶$289.6KraisedMay 2015 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Henry MellonDirector
  • Holger WeisExecutive Officer
  • Jeffrey L. RaneyExecutive Officer
  • Charles KoobDirector
  • Bruce HackDirector
  • Peter NejesDirector
  • Steve GorlinDirector
  • Skip ClemmonsDirector
Offering amount
$500K
Amount sold
$289.6K
Minimum investment
$1K
First sale
Apr 2015
Incorporated
Corporation, Florida, 2010
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does DemeRx do?
DemeRx develops psychedelic-based medications to treat addiction and mental health conditions. The company advances clinical trials for ibogaine and related compounds targeting alcohol use disorder and opioid addiction.
Who founded DemeRx?
DemeRx was founded by Deborah C. Mash in 2010.
How much funding has DemeRx raised?
DemeRx has disclosed $289.6K raised across 1 round.
Where is DemeRx headquartered?
DemeRx is headquartered in Fort Lauderdale, US.